Devices & Diagnostics

Sisu Global Health announces new funding for its Hemafuse blood recycling device

The handheld device, the Hemafuse, allows doctors to recycle blood from patients with internal bleeding, reducing the need for donor blood. It collects blood from an internal hemorrhage and is designed to be used in emergency situations.

Sisu Global Health

Baltimore-based Sisu Global Health has announced $200,000 in funding from the Abell Foundation to further progress of its medical device created to be used in the developing world.

The handheld device, the Hemafuse, allows doctors to recycle blood from patients with internal bleeding, reducing the need for donor blood. It collects blood from an internal hemorrhage and is designed to be used in emergency situations.

The device is a semi-reusable device that can be used up to 50 times with one-time-use, disposable filters. In between uses, the main body of the device is sterilized.

Sisu’s website cites this somewhat astonishing data point stated by the US Department of Commerce: “80 percent of the medical equipment in the world is only designed for 10 percent of the world’s population.”

The company, which took part in the Dreamit Health Baltimore accelerator, is focused on creating innovative solutions for populations that don’t always have access to sufficient emergency care. The Hemafuse and the company’s other device, (R) a modular centrifuge that can separate blood both with or without electricity in just 3 minutes, are both patent-pending.

Sisu is currently working with the goal to raise $1 million to increase production. Back in September, AOL CEO Steve Case invested $100,000 in the company after it won the live pitch competition “Rise of the Rest Road Trip” in Baltimore.

The company moved to Baltimore from Michigan in 2015 when it brought in an investment from DreamIt Health.

Photo: Screenshot via Sisu Global Health

Shares0
Shares0